Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

111, Inc. YI NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
29/100
1/5 Pass
SharesGrow Intrinsic Value
$32.89
+383%

111, Inc. (YI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Les analystes estiment Bénéfice par action (EPS) de $3.57 et chiffre d'affaires de $2.12B pour le prochain exercice fiscal.

Historique du Bénéfice par action (EPS): 2024: réel $-7.52 vs est $3.57 (manqué -310.8%). Précision des analystes: 0%.

Estimations du BPA — YI

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$7.52 vs Est $3.57 ▼ 147.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Estimations du CA — YI

15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $14.401B vs Est $2.122B ▲ 85.3% off
Revenue Trend
Analysts expect stable revenue going forward.
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message